World's Best Scientists 2026 revealed!
Silvio E. Inzucchi

Silvio E. Inzucchi

D-Index & Metrics

Medicine

D-Index
125
Citations
100071
World Ranking
3009
National Ranking
1664

Overview

Silvio E. Inzucchi is affiliated with Yale University in the United States. Their research primarily spans the field of Medicine, with a concentration in Endocrinology, Diabetes and Metabolism, as well as Cardiology and Cardiovascular Medicine. Other notable subfields include Surgery, Molecular Biology, and Pulmonary and Respiratory Medicine.

The main topics covered in their work include Diabetes Treatment and Management, Pancreatic Function and Diabetes, Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Metabolism, Diabetes and Cancer, Diabetes Management and Research, and Chronic Kidney Disease and Diabetes.

Some of their recent papers are:

  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (2022) published in New England Journal of Medicine
  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease (2020) published in New England Journal of Medicine
  • Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials (2022) published in The Lancet
  • SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials (2022) published in The Lancet
  • Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes (2020) published in JAMA

Frequent co-authors in their collaborations include:

  • John J.V. McMurray
  • Mikhail Kosiborod
  • Scott D. Solomon
  • Pardeep S. Jhund
  • Felipe A. Martínez

Their publications have appeared repeatedly in high-profile venues, including:

  • Circulation (34 publications)
  • Journal of the American College of Cardiology (24 publications)
  • European Journal of Heart Failure (22 publications)
  • European Heart Journal (22 publications)
  • JACC Heart Failure (22 publications)

Silvio E. Inzucchi's research contributions focus heavily on the interplay of diabetes and cardiovascular conditions, especially in the context of treatment management involving sodium glucose co-transporter-2 (SGLT2) inhibitors. Their work also addresses the implications of diabetes on kidney outcomes and heart failure progression, reflecting interdisciplinary intersections between endocrinology, cardiology, and nephrology.

Best Publications

  • Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

    Bernard Zinman;Christoph Wanner;John M. Lachin;David Fitchett

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Silvio E Inzucchi;Richard M Bergenstal;John B Buse;Michaela Diamant

  • Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

    Etie S. Moghissi;Mary T. Korytkowski;Monica DiNardo;Daniel Einhorn

  • Oral Antihyperglycemic Therapy for Type 2 Diabetes: Scientific Review

    Silvio E. Inzucchi

  • Mechanism by which metformin reduces glucose production in type 2 diabetes.

    Ripudaman S. Hundal;Martin Krssak;Sylvie Dufour;Didier Laurent

  • Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379

    SE Inzucchi;RM Bergenstal;JB Buse;M Diamant

  • How Do We Define Cure of Diabetes

    John B. Buse;Sonia Caprio;William T. Cefalu;Antonio Ceriello

  • Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

    W. N. Kernan;C. M. Viscoli;K. L. Furie;L. H. Young

  • Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

    Silvio E. Inzucchi;David G. Maggs;Geralyn R. Spollett;Stephanie L. Page

  • Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study.

    Frans J Th Wackers;Lawrence H Young;Silvio E Inzucchi;Deborah A Chyun

  • Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

    David Fitchett;Bernard Zinman;Bernard Zinman;Christoph Wanner;John M. Lachin

  • Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.

    Lawrence H. Young;Frans J. Th. Wackers;Deborah A. Chyun;Janice A. Davey

  • Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

    Ripudaman S. Hundal;Kitt F. Petersen;Adam B. Mayerson;Pritpal S. Randhawa

  • Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

    Caroline S. Fox;Sherita Hill Golden;Cheryl Anderson;George A. Bray

  • Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.

    Mikhail Kosiborod;Saif S. Rathore;Silvio E. Inzucchi;Frederick A. Masoudi

  • Erratum: Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (Diabetologia (2013) 56 (680))

    S. E. Inzucchi;R. M. Bergenstal;John B Buse;M. Diamant

  • Standards of Medical Care in Diabetes—2008: Response to Dora, Kramer, and Canani

    Irl B. Hirsch;Irl B. Hirsch;Silvio E. Inzucchi;Silvio E. Inzucchi;M. Sue Kirkman

Frequent Co-Authors

Mikhail Kosiborod
Mikhail Kosiborod University of Missouri–Kansas City
Christoph Wanner
Christoph Wanner University of Würzburg
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Bernard Zinman
Bernard Zinman University of Toronto
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Subodh Verma
Subodh Verma University of Toronto
Lars Køber
Lars Køber Copenhagen University Hospital
John J.V. McMurray
John J.V. McMurray University of Glasgow
Pardeep S. Jhund
Pardeep S. Jhund University of Glasgow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can provide flexible entry points and advancement opportunities in the healthcare sector. For registered nurses wanting to broaden their scope, asn to fnp programs offer a direct bridge from associate-level training to advanced nursing roles, preparing graduates for positions as Family Nurse Practitioners.

Those interested in specialized care or hospital management may consider pursuing an online mha programs cahme accredited. These programs help students develop leadership skills and business acumen for healthcare administration positions.

Many students seek science backgrounds before applying to medical school. If you have a particular interest in patient wellness or dietetics, earning one of the many online nutrition degrees can support careers in nutrition counseling or health education.

Finally, nurses aiming to advance without extensive in-person commitments can benefit from rn to bsn without clinicals. These programs enable RNs to earn higher credentials conveniently and flexibly, boosting employability and future study options.

Best Scientists Citing Silvio E. Inzucchi

Trending Scientists